Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Biron

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Antiviral Research|April 1, 1995
Molecular mechanisms of antiviral resistanceD W Kimberlin, D M Coen, K K Biron, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activityW H Miller, L M Beauchamp, E Meade, et al.
Journal of Virology|February 1, 1995
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolateF Baldanti, E Silini, A Sarasini, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirusMark R Underwood, Robert G Ferris, Dean W Selleseth, et al.
Advances in Experimental Medicine and Biology|November 5, 1999
Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus diseaseJ Chulay, K Biron, L Wang, et al.
American Journal of Ophthalmology|November 13, 2001
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8D A Jabs, B K Martin, M S Forman, et al.
Antiviral Research|April 1, 1995
Antiviral resistance in clinical practiceD W Kimberlin, C S Crumpacker, S E Straus, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirusPaula M Krosky, Katherine Z Borysko, M Reza Nassiri, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Journal of Virology|May 30, 1998
Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56P M Krosky, M R Underwood, S R Turk, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Antiviral Research|April 1, 1995
Molecular mechanisms of antiviral resistanceD W Kimberlin, D M Coen, K K Biron, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activityW H Miller, L M Beauchamp, E Meade, et al.
Journal of Virology|February 1, 1995
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolateF Baldanti, E Silini, A Sarasini, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirusMark R Underwood, Robert G Ferris, Dean W Selleseth, et al.
Advances in Experimental Medicine and Biology|November 5, 1999
Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus diseaseJ Chulay, K Biron, L Wang, et al.
American Journal of Ophthalmology|November 13, 2001
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8D A Jabs, B K Martin, M S Forman, et al.
Antiviral Research|April 1, 1995
Antiviral resistance in clinical practiceD W Kimberlin, C S Crumpacker, S E Straus, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirusPaula M Krosky, Katherine Z Borysko, M Reza Nassiri, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Journal of Virology|May 30, 1998
Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56P M Krosky, M R Underwood, S R Turk, et al.
Pageof 8